Williams Jones Wealth Management’s Epizyme, Inc EPZM Stock Holding History

Williams Jones Wealth Management’s Portfolio EPZM Stock Details EPZM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,555	Closed	-$23K	–	601
2022 Q2	$23K	Buy	15,555 +4,500	+41%	+$3.31K	﹤0.01%	560
2022 Q1	$13K	Hold	11,055	–	–	﹤0.01%	525
2021 Q4	$28K	Sell	11,055 -76,745	-87%	-$302K	﹤0.01%	489
2021 Q3	$450K	Sell	87,800 -40,498	-32%	-$246K	0.01%	336
2021 Q2	$1.07M	Buy	128,298 +2,000	+2%	+$16.9K	0.01%	243
2021 Q1	$1.1M	Sell	126,298 -15,021	-11%	-$155K	0.02%	238
2020 Q4	$1.53M	Buy	141,319 +14,164	+11%	+$175K	0.03%	206
2020 Q3	$1.52M	Buy	+127,155	New	+$1.7M	0.03%	180

Other funds holding EPZM

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Williams Jones Wealth Management's EPZM Position: Q3 2022 in Review

Williams Jones Wealth Management sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 15,555 shares — an estimated $23K sold.

Williams Jones Wealth Management first reported a position in EPZM in Q3 2020 and held it in 8 quarters. The position peaked at $1.53M in Q4 2020. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.

Williams Jones Wealth Management reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
Williams Jones Wealth Management sold 15,555 Epizyme, Inc shares in Q3 2022, an estimated $23K.
Williams Jones Wealth Management first reported a position in Epizyme, Inc in Q3 2020 and held it in 8 quarters.
Williams Jones Wealth Management's Epizyme, Inc position peaked at $1.53M in Q4 2020.
0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.

Based on Williams Jones Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.